IN THE NEWS

News

22February2024

Ritedose, South Carolina’s Leading Pharmaceutical Manufacturer, Buys 105 Acres of Land for Major Expansion.

Columbia, S.C. (February 22, 2024) — The Ritedose Corporation (Ritedose) today announced a major expansion of its rapidly-growing pharmaceutical company with the recent purchase of 105 acres from the Midlands Technical College Enterprise Campus in Richland Northeast. (more…)

exterior of a campus from afar in the daytime with text overlay: 105 acres acquired Ritedose expands

24August2023

Ritedose Pharmaceuticals Launches Cromolyn Sodium Inhalation Solution, USP (20 mg/2 ml)

COLUMBIA, S.C. (August 24, 2023) – Ritedose, a pharmaceutical manufacturer located in South Carolina, launched a new sterile unit dose generic product, Cromolyn Sodium Inhalation Solution, USP (20 mg/2 ml). The single-dose vial product joins a range of other inhalation…

box with yellow label of cromolyn sodium inhalation solution with text overly: available now

13April2023

Ritedose Pharmaceuticals Launches New Product: Arformoterol Tartrate Inhalation Solution (15 mcg/2 ml)

COLUMBIA, S.C. (April 13, 2023) – Ritedose, a pharmaceutical manufacturer located in South Carolina, just launched a new single unit dose oral inhalation product, Arformoterol Tartrate (15 mcg/2 ml), making the company the largest generic drug maker of its kind.…

box with blue label of arformoterol tartrate inhalation solution with text overly: available now

11October2022

Ritedose Reaches Milestone with Asset Purchase

COLUMBIA, S.C.—The Ritedose Corporation, LLC now offers the most complete nebulized inhalation drug portfolio in the industry with the purchase of the Arformoterol Tartrate asset from PAI Pharma of Greenville, S.C. (more…)

panoramic photo featuring Ritedose's main campus with text overlay: Ritedose becomes the largest generic drug maker of its kind

18January2022

The Ritedose Corporation Announces Revolutionary Liquid Med Dispenser SuredoseRx™ to launch in first quarter

COLUMBIA, S.C. (January 18) — The Ritedose Corporation has announced the development of and plans to commercialize the first new way to dispense single-dose liquid medications in two decades. After five years of R&D, the Columbia-based developer of blow-fill-seal unit…

an array of liquid tubes and packaging featuring Ritedose's SuredoseRx shown in front of a factory with text overlay: precision dosing made easy

5January2022

Ritedose Pharmaceuticals Launches Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 ml

COLUMBIA, S.C. (January 5, 2022) – Ritedose, a pharmaceutical manufacturer located in South Carolina, just launched a new single unit dose generic product, Cromolyn Sodium Oral Solution (Concentrate), 100 mg/5 ml. The oral solution is the first of a new…

box with blue label of cromolyn sodium oral solution with text overly: available now

4January2022

Novo Holdings to acquire Ritedose

COPENHAGEN, Denmark, Jan. 4, 2022 /PRNewswire/ – Founded in 1995 and headquartered in Columbia, S.C., The Ritedose Corporation (“Ritedose”) is a leading sterile pharmaceutical manufacturer, specialising in the use of blow-fill-seal (BFS) technology. Ritedose provides outsourced development and manufacturing of…

10September2021

Ritedose Launches Critical Care Single-Dose Syringe Product Amid National Shortage: Atropine Sulfate Injection 1.2 mg/3 mL (0.4 mg/mL)

COLUMBIA, S.C. (September 10, 2021) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched a new unit dose syringe product, Atropine Sulfate Injection 1.2 mg/3 mL (0.4 mg/mL). It is the last of a 12-product, six-month rollout…

19November2020

Ritedose to Produce Single-Dose Prefilled Syringes for COVID-19 Vaccines

“The Ritedose Corporation is honored and proud to have been selected as a subcontractor to ApiJect for the production of single-dose prefilled syringes intended for administering COVID-19 vaccines. This is a direct result of the commitment demonstrated each day by…

robotic arm stacking boxes on manufacturing floor with text overlay: Ritedose commitment to health scaling up vaccine production

20August2020

New pavilion in Columbia to serve as e-learning location for homeless children

COLUMBIA, S.C. (COLA DAILY) — The Columbia-based nonprofit, Homeless No More, unveiled a new pavilion Thursday morning to serve as a shady spot for families and children to gather. It will be available to the families using the organization’s emergency/transitional…

group of children standing under a pavilion with text overlay: e-learning location for homeless children

20August2020

Local nonprofit receives new pavilion to help homeless families with children

Columbia, S.C. (WOLO) — There’s now a new outdoor pavilion to help families at ‘Homeless No More of Columbia,’ a local nonprofit that helps homeless families stay together and become self-sufficient. The pavilion offers a space for the children to…

closeup of Jody Chastain and a teen boy cutting a ribbon to celebrate the opening of a new pavilion for the homeless with text overlay: standing with our community

20August2020

As surge in evictions loom, Columbia non-profit expands resources

COLUMBIA, S.C. (WIS) – For the non-profit Homeless No More, Thursday was an opportunity to celebrate. The organization, which provides emergency, transitional, and low-cost housing for those struggling with homelessness, hosted a ribbon-cutting for a new pavilion at its complex,…

exterior daytime photo of a wooden pavilion with text overlay: helping those In need

FEATURED NEWS

18th June 2025

Ritedose Unveils State-of-the-Art Distribution and Logistics Facility at Ritedose Performance Park

Stakeholders open the Ritedose distribution and logistics facility at Performance Park. L–R: Brian Taylor, VP Business Development, Miller Valentine Construction Jeff Ruble, Director, Richland County Economic Development Ashely Teasdel, Deputy Secretary, SC Dept. of Commerce Jody Chastain, CEO, Ritedose Jesica Mackey, Richland County Council District 9 Daniel Rickenmann, Mayor, City of Columbia Ronald Rhames, Fmr. President, Midlands Technical College Greg Little, President, Midlands Technical College

15th April 2025

Ritedose Adds Seventh Syntegon Packaging Line to Expand Single Vial Packaging Capabilities, Support Production of new COPD Drug Ohtuvayre

single-vial packaging line in manufacturing facility

16th September 2024

Ritedose is Proud to Partner with Verona Pharma to Deliver First-In-Class COPD Drug, Ohtuvayre (ensifentrine)*

Ohtuvayre box with two individually wrapped vials with text overlay: development and manufacturing partner

11th July 2024

Ritedose, the Leading Pharmaceutical Manufacturer (CDMO) Specializing in Sterile Blow-Fill-Seal, Expands its BFS Capacity to Meet the Growing Demand f…

interior of large warehouse with forklifts in foreground and text overlay: we are expanding

18th January 2022

RECEIVE THE LATEST NEWS

Get a healthy dose of all things Ritedose. Subscribe now for breaking news alerts, updates, previews, and more.

News

Ritedose, South Carolina’s Leading Pharmaceutical Manufacturer, Buys 105 Acres of Land for Major Expansion.

Ritedose Pharmaceuticals Launches Cromolyn Sodium Inhalation Solution, USP (20 mg/2 ml)

Ritedose Pharmaceuticals Launches New Product: Arformoterol Tartrate Inhalation Solution (15 mcg/2 ml)

Ritedose Reaches Milestone with Asset Purchase

The Ritedose Corporation Announces Revolutionary Liquid Med Dispenser SuredoseRx™ to launch in first quarter

Ritedose Pharmaceuticals Launches Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 ml

Novo Holdings to acquire Ritedose

Ritedose Launches Critical Care Single-Dose Syringe Product Amid National Shortage: Atropine Sulfate Injection 1.2 mg/3 mL (0.4 mg/mL)

Ritedose to Produce Single-Dose Prefilled Syringes for COVID-19 Vaccines

New pavilion in Columbia to serve as e-learning location for homeless children

Local nonprofit receives new pavilion to help homeless families with children

As surge in evictions loom, Columbia non-profit expands resources

FEATURED NEWS

Ritedose Unveils State-of-the-Art Distribution and Logistics Facility at Ritedose Performance Park

Ritedose Adds Seventh Syntegon Packaging Line to Expand Single Vial Packaging Capabilities, Support Production of new COPD Drug Ohtuvayre

Ritedose is Proud to Partner with Verona Pharma to Deliver First-In-Class COPD Drug, Ohtuvayre (ensifentrine)*

Ritedose, the Leading Pharmaceutical Manufacturer (CDMO) Specializing in Sterile Blow-Fill-Seal, Expands its BFS Capacity to Meet the Growing Demand f…

The Ritedose Corporation Announces Revolutionary Liquid Med Dispenser SuredoseRx™ to launch in first quarter

Novo Holdings to acquire Ritedose

Ritedose Efficiency Innovation Yields Up to 25% Increase in CDMO Production Capability

RECEIVE THE LATEST NEWS

TAGS CLOUD

Quick Links

Receive the latest news.

News

FEATURED NEWS

RECEIVE THE LATEST NEWS

TAGS CLOUD

Tags

Quick Links

Receive the latest news.